Literature DB >> 27090969

A Japanese familial ALS patient with autonomic failure and a p.Cys146Arg mutation in the gene for SOD1 (SOD1).

Kentaro Hayashi1, Yoko Mochizuki2,3, Reiji Koide1,4, Akihiro Kawata1, Taku Homma2,5, Toshio Shimizu1, Takashi Komori2, Eiji Isozaki1.   

Abstract

We describe a Japanese man with familial amyotrophic lateral sclerosis (ALS) associated with a p.Cys146Arg mutation in the copper/zinc superoxide dismutase gene (SOD1). The patient developed bulbar signs followed by rapidly progressive limb muscle weakness. The prominent clinical feature was orthostatic hypotension due to autonomic failure, which occurred after he underwent tracheostomy 1 year and 3 months after the onset. Thereafter, he required mechanical ventilation and progressed to communication stage V (totally locked-in state) 7 years after the onset. Neuropathology showed ALS with posterior column degeneration and multiple system degeneration. Severe neuronal loss in the intermediolateral nucleus was also observed. Two previously reported cases of ALS patients with autonomic failure showed severe neuronal loss in the intermediolateral nucleus in addition to degeneration of the motor neurons. Thus, autonomic failure due to neuronal loss in the intermediolateral nucleus could present in patients with ALS associated with certain mutations in SOD1.
© 2016 Japanese Society of Neuropathology.

Entities:  

Keywords:  SOD1; autonomic failure; familial ALS; orthostatic hypotension; p.Cys146Arg

Mesh:

Substances:

Year:  2016        PMID: 27090969     DOI: 10.1111/neup.12303

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  4 in total

1.  Early presentation of lower urinary tract and bowel dysfunction in sporadic amyotrophic lateral sclerosis: A case report.

Authors:  Masataka Nakamura; Kentaro Nakayama; Aya Murakami; Satoshi Morise; Satoshi Kaneko; Hirofumi Kusaka; Yusuke Yakushiji
Journal:  eNeurologicalSci       Date:  2022-06-18

Review 2.  Pathophysiology and Treatment of Non-motor Dysfunction in Amyotrophic Lateral Sclerosis.

Authors:  Colin J Mahoney; Rebekah M Ahmed; William Huynh; Sicong Tu; Jonathan D Rohrer; Richard S Bedlack; Orla Hardiman; Matthew C Kiernan
Journal:  CNS Drugs       Date:  2021-05-15       Impact factor: 5.749

3.  Clinical and Molecular Landscape of ALS Patients with SOD1 Mutations: Novel Pathogenic Variants and Novel Phenotypes. A Single ALS Center Study.

Authors:  Emilien Bernard; Antoine Pegat; Juliette Svahn; Françoise Bouhour; Pascal Leblanc; Stéphanie Millecamps; Stéphane Thobois; Claire Guissart; Serge Lumbroso; Kevin Mouzat
Journal:  Int J Mol Sci       Date:  2020-09-16       Impact factor: 5.923

4.  Clinicopathological characteristics of patients with amyotrophic lateral sclerosis resulting in a totally locked-in state (communication Stage V).

Authors:  Kentaro Hayashi; Yoko Mochizuki; Ryoko Takeuchi; Toshio Shimizu; Masahiro Nagao; Kazuhiko Watabe; Nobutaka Arai; Kiyomitsu Oyanagi; Osamu Onodera; Masaharu Hayashi; Hitoshi Takahashi; Akiyoshi Kakita; Eiji Isozaki
Journal:  Acta Neuropathol Commun       Date:  2016-09-30       Impact factor: 7.801

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.